Literature DB >> 1506332

In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp.

K Yazawa1, Y Mikami, S Ohashi, M Miyaji, Y Ichihara, C Nishimura.   

Abstract

MICs of two new carbapenems, meropenem and L-627, and imipenem were determined against 98 strains of the Nocardia asteroides group (i.e. N. asteroides sensu stricto, Nocardia farcinica and Nocardia nova), 46 strains of Nocardia brasiliensis and 17 strains of Nocardia otitidiscaviarum. Meropenem and L-627 were less active against the N. asteroides group than imipenem. Among the three species of the N. asteroides group, N. nova was the most sensitive to all the carbapenems. Meropenem was more active than imipenem against both N. brasiliensis and N. otitidiscaviarum with MIC50 values of 28.3-53.3 mg/L. L-627 was less active than meropenem.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506332     DOI: 10.1093/jac/29.2.169

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  A mimic's imitator: a cavitary pneumonia in a myasthenic patient with history of tuberculosis.

Authors:  Raquel Ramos Garcia; Nitin Bhanot; Zaw Min
Journal:  BMJ Case Rep       Date:  2015-07-06

2.  In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.

Authors:  Barbara A Brown-Elliott; Jessica Killingley; Sruthi Vasireddy; Linda Bridge; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

3.  Pneumonia involving Aspergillus and Rhizopus spp. after a near-drowning incident with subsequent Nocardia cyriacigeorgici and N. farcinica coinfection as a late complication.

Authors:  A P van Dam; M T C Pruijm; B I J Harinck; L B S Gelinck; E J Kuijper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

4.  Inactivation of rifampin by Nocardia brasiliensis.

Authors:  K Yazawa; Y Mikami; A Maeda; M Akao; N Morisaki; S Iwasaki
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

Review 5.  Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

Authors:  J A Balfour; H M Bryson; R N Brogden
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

6.  Two cases of multidrug-resistant Nocardia farcinica infection in immunosuppressed patients and implications for empiric therapy.

Authors:  W Hitti; M Wolff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

7.  Nocardia exalbida brain abscess in a patient with follicular lymphoma.

Authors:  Makiko Ono; Yukio Kobayashi; Tsuyoshi Shibata; Dai Maruyama; Sung-Won Kim; Takashi Watanabe; Yuzuru Mikami; Kensei Tobinai
Journal:  Int J Hematol       Date:  2008-05-23       Impact factor: 2.490

8.  Inactivation of the macrolide antibiotics erythromycin, midecamycin, and rokitamycin by pathogenic Nocardia species.

Authors:  K Yazawa; Y Mikami; T Sakamoto; Y Ueno; N Morisaki; S Iwasaki; K Furihata
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 9.  Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  L R Wiseman; A J Wagstaff; R N Brogden; H M Bryson
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

10.  Disseminated Nocardia farcinica infection in an AIDS patient.

Authors:  G D Miralles
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.